Overview
Updated 14 Jul 2026
Ticiana Leal, MD, is Professor, Department of Hematology and Medical Oncology at Emory University / Winship Cancer Institute of Emory University, Atlanta, GA. The public record shows 190 publications with 9,534 citations (h-index 33), centered on Lung Cancer (NSCLC/SCLC). It also documents an investigator role on 9 registered clinical trials, industry payments reported by 32 companies, 1 NIH-funded awards (2022–2025).
- Most recent indexed publication: 2026 · JCO oncology practice
- Top research focus: Lung Cancer (NSCLC/SCLC)
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 32 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 18 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Sponsor: Nuvalent Inc.
InvestigatorPhase 3RecruitingNCT06765109 - Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
Sponsor: National Cancer Institute (NCI)
InvestigatorPhase 1/PHASE2RecruitingNCT06287775 - A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Sponsor: Eli Lilly and Company
InvestigatorPhase 3RecruitingNCT06119581
Industry payments
Updated 14 Jul 2026
32 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Novocure Inc.Program year20258 payments$90,202openpaymentsdata.cms.gov ↗
- Amgen Inc.Program year20256 payments$39,374openpaymentsdata.cms.gov ↗
- JAZZ PHARMACEUTICALS INC.Program year202530 payments$38,973openpaymentsdata.cms.gov ↗
NIH funding
Updated 14 Jul 2026
1 NIH research award on record, funded 2022–2025 per NIH RePORTER. The latest:
- ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
Emory University
FY2025$683,484UG1CA233259 - ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
Emory University
FY2024$683,484UG1CA233259 - ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
Emory University
FY2023$621,608UG1CA233259
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Inhibition of hTERT/telomerase/telomere mediates therapeutic efficacy of osimertinib in EGFR mutant lung cancer.
The Journal of experimental medicine
2024
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
1365 Clifton Road NE, Building C Floor 2, Atlanta, GA 30322
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.emoryhealthcare.org ↗
Editorial & leadership rolesjournal and society appointments
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iaslc.org ↗
- Associate Editor and Executive Editorial Board Member
The Journal of the National Comprehensive Cancer Network (JNCCN)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗ - Lung Cancer Section Editor
Current Treatment Options in Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗
Awards & honorshonors on the public record
- Recognized with a Lifetime Achievement Award at the Illuminate 3.0 Oncology Town Hall
Mumbai, India (date not specified)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Secondary affiliationsappointments beyond the home institution
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pub.orcid.org ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vjoncology.com ↗
- ASCO Post video: co-presented with Narjust Florez
MD, on metastatic NSCLC Tumor Treating Fields therapy
2023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/ticiana-leal-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
winshipcancer.emory.edu/profiles/leal-ticiana.php
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗ - ResearchGate
researchgate.net/scientific-contributions/Ticiana-Leal-2314989684
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by otherswhere others cite or feature them
- LinkedIn
linkedin.com/posts/winship-cancer-institute_congrats-to-ticiana-leal-md-who-has-been-activity-7203817825935704065-sHUI
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
onclive.com/view/variability-and-innovation-in-small-cell-lung-cancer-care-with-ticiana-leal-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Suresh Ramalingam, MBBS
Emory University
- 1,240
- publications
- 125
- h-index
- 14
- trials
Arshed Quyyumi, MD
Emory University
- 1,130
- publications
- 107
- h-index
- 27
- trials
Bruce Bode, MD
Emory University
- 373
- publications
- 84
- h-index
- 19
- trials
Nadine Rouphael, MD
Emory University
- 375
- publications
- 62
- h-index
- 23
- trials